Concepedia
Statistics
Publications
10
Citations
1.1K
H-Index
Active since
2005
Affiliations
Altimmune (United States)(Current)
Fondazione IRCCS Istituto Nazionale dei Tumori
AstraZeneca (United States)
University of North Carolina at Chapel Hill
Dana-Farber Cancer Institute
Nicholas Holoweckyj is an author at Altimmune (United States) specializing in medicine, oncology, and cancer immunotherapy.
Publications per year
2005–2023
IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE
Shu Wang, Jingya Wang, Varsha Kumar et al. · Nature Communications · 2018 · 569 citations · Full text
Life Sciences, Immunology, Nephrology +17
Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models
Jonathan Rios‐Doria, Nicholas M. Durham, Leslie Wetzel et al. · Neoplasia · 2015 · 172 citations · Full text
Medicine, Oncology, Pharmacology +17
Phosphorylation of Coronin 1B by Protein Kinase C Regulates Interaction with Arp2/3 and Cell Motility
Liang Cai, Nicholas Holoweckyj, Michael D. Schaller et al. · Journal of Biological Chemistry · 2005 · 119 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +14
A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist
Rebecca Leyland, Amanda Watkins, Kathy Mulgrew et al. · Clinical Cancer Research · 2017 · 52 citations
PD-L1 <sup>+</sup> neutrophils contribute to injury-induced infection susceptibility
Ajitha Thanabalasuriar, Abby J. Chiang, Christopher Morehouse et al. · Science Advances · 2021 · 46 citations · Full text
Veterinary Medicine, Immunology, Pathobiology +11
1–5 of 10